| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.54M | - | |
| CFO | 215.4K | $1.79M | - | |
| Dir | 119.9K | $998.4K | - | |
| VP | 104.1K | $867.2K | - | |
| Dir | 89.0K | $741.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2020 | El-Hibri Fuad | Chairman | Sell | 35,869 | $62.49 | $2,241,615.60 | -0.9% | |
| Apr 9, 2020 | El-Hibri Fuad | Chairman | Sell | 61,078 | $61.40 | $3,750,475.36 | -1.4% | |
| Apr 7, 2020 | El-Hibri Fuad | Chairman | Sell | 42,576 | $60.59 | $2,579,575.36 | -1.5% | |
| Apr 6, 2020 | Kirk Sean | EVP, Manufacturing &Tech Ops | Sale+OE | 16,094 | $60.00 | $965,640.00 | -29.9% | |
| Apr 6, 2020 | Havey Adam | EVP, Business Operations | Sell | 7,972 | $60.00 | $478,320.00 | -9.9% | |
| Mar 16, 2020 | Harsanyi Zsolt | Director | Sell | 6,400 | $65.00 | $416,000.00 | -17.6% | |
| Mar 4, 2020 | Zoon Kathryn C62 | Director | Sell | 991 | $60.65 | $60,103.46 | -5.7% | |
| Mar 4, 2020 | Sullivan Louis W62 | Director | Sale+OE | 15,786 | $58.96 | $930,714.15 | -11.5% | |
| Feb 27, 2020 | Bailey Sue | Director | Sell | 6,572 | $56.93 | $374,132.13 | -14.2% | |
| Feb 27, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 23,456 | $57.97 | $1,359,849.19 | -0.8% |